Connecticut 2022 2022 Regular Session

Connecticut House Bill HB05400 Introduced / Fiscal Note

Filed 05/04/2022

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
HB-5400 
AN ACT CONCERNING THE REGULATION OF INSURANCE IN 
THE STATE. 
As Amended by House "A" (LCO 6461) 
House Calendar No.: 232  
 
Primary Analyst: MP 	5/4/22 
Contributing Analyst(s): ME, CP, RJW   
 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 23 $ FY 24 $ 
Office of Health Strategy GF - Cost 300,000 None 
Consumer Protection, Dept. GF - Cost 75,000 90,418 
State Comptroller - Fringe 
Benefits
1
 
GF - Cost 30,398 36,646 
Note: GF=General Fund  
Municipal Impact: None  
Explanation 
The bill makes various changes related to health insurance and 
prescription drugs, and results in the fiscal impacts described by section 
below. 
Section 1 and 16 make changes related to disclosing the process for 
step therapy overrides and the time permitted for an override request 
to be granted for drugs treating certain conditions. These changes are 
not anticipated to impact premiums for the state employee health plan 
or municipal plans, as the override request process already exists. 
Section 2 establishes a task force to study data collection efforts 
regarding step therapy, which has no fiscal impact because PA 17-236 
 
1
The fringe benefit costs for most state employees are budgeted centrally in accounts 
administered by the Comptroller. The estimated active employee fringe benefit cost 
associated with most personnel changes is 40.53% of payroll in FY 23.  2022HB-05400-R01-FN.DOCX 	Page 2 of 3 
 
 
prohibits transportation allowances for task force members. 
Sections 3-5 apply the state’s copay accumulator program 
prohibition to high deductible health plans to the maximum extent 
permitted by federal law, which results in no fiscal impact to the state 
and municipalities.  
Sections 6 and 7 extend the notification period that insureds must 
notify insurers regarding the birth of a child, from 61 days to 91 days. 
The bill specifies that claims during the extended period are not 
prejudiced if notification or payment of premium is not provided, and 
therefore there is no anticipated impact to premiums to the state 
employee health plan, the Exchange, or municipal plans. 
Sections 8-13 require the Department of Consumer Protection (DCP) 
to establish a Canadian Legend Drug Importation Program (CLDIP) 
resulting in costs of approximately $75,000 to DCP (salary) and $30,398 
to OSC (fringe benefits) in FY 23, and $90,418 to DCP (salary) and 
$36,646 to OSC (fringe benefits) in FY 24 and each fiscal year thereafter. 
In FY 23 only, a six-month durational Project Manager is needed to 
submit a request to the federal Secretary of Health and Human Services 
for approval to establish the CLDIP. Assuming federal approval is 
granted, a full-time Drug Control Agent will be needed to run the 
program beginning in FY 24. 
Section 14 requires the Office of Health Strategy (OHS) to prepare 
and submit a report on pharmacy benefit manager distribution of 
prescription drug practices regarding spread pricing arrangements, 
manufacturing rebates and transparency and accountability. OHS will 
need to hire a consultant, with a one-time cost estimated at $300,000 to 
prepare this report as OHS staff does not have expertise in this area. 
Section 15, which requires the State Comptroller to prepare and 
submit a report, has no fiscal impact since the agency has enough 
expertise within existing staff resources to conduct the study. 
  2022HB-05400-R01-FN.DOCX 	Page 3 of 3 
 
 
The Out Years 
The annualized ongoing fiscal impact identified above would 
continue into the future subject to inflation.  
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely 
for the purposes of information, summarization and explanation and does not represent the intent of the General 
Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of 
informational sources, including the analyst’s professional knowledge. Whenever applicable, agency data is 
consulted as part of the analysis, however final products do not necessarily reflect an assessment from any 
specific department.